Drug release from nanomedicines: Selection of appropriate encapsulation and release methodology

Drug Delivery and Translational Research

Volumn 2, Issue 4, 2012, Pages 284-292

  Wallace, Stephanie J ^a   Li, Jian ^a   Nation, Roger L ^a   Boyd, Ben J ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Centrifuge ultrafiltration; Dynamic light scattering; Encapsulation efficiency; In vitro release; Nanoparticle; Pressure ultrafiltration; Ultracentrifugation

Indexed keywords

COLISTIN; DIOLEOYLPHOSPHATIDYLCHOLINE; LIPOSOME; NANOPARTICLE;

ARTICLE; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; ENCAPSULATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; KINETICS; LIGHT SCATTERING; METHODOLOGY; NANOMEDICINE; PARTICLE SIZE; PHYSICAL PHASE; PRESSURE; PRIORITY JOURNAL; ULTRACENTRIFUGATION; ULTRAFILTRATION;

EID: 84864040485     PISSN: 2190393X     EISSN: 21903948     Source Type: Journal    
DOI: 10.1007/s13346-012-0064-4     Document Type: Article

References (35)

1. Washington C. Drug release from microdisperse systems: a critical review. Int J Pharm. 1990; 58: 1-12.
2. Herman EH, Rahman A, Ferrans VJ, Vick JA, Schein PS. Prevention of chronic doxorubicin cardiotoxicity in beagles by liposomal encapsulation. Cancer Res. 1983; 43: 5427-32.
3. Barenholz Y. Relevancy of drug loading to liposomal formulation therapeutic efficacy. J Liposome Res. 2003; 13: 1-8.
4. Washington C, Koosha F. Drug release from microparticles: denconvolution of measurement errors. Int J Pharm. 1990; 59: 79-82.
5. Magenheim B, Levy MY, Benita S. A new in vitro rechnique for the evaluation of drug release profile from colloidal carriers-ultrafiltration technique at low pressure. Int J Pharm. 1993; 94: 115-23.
6. Ricci M, Giovagnoli S, Blasi P, Schoubben A, Perioli L, Rossi C. Development of liposomal capreomycin sulfate formulations: effects of formulation variables on peptide encapsulation. Int J Pharm. 2006; 311: 172-81.
7. Zheng Y, Wu Y, Yang W, Wang C, Fu S, Shen X. Preparation, characterization, and drug release in vitro of chitosan-glycyrrhetic acid nanoparticles. J Pharm Sci. 2006; 95: 181-91.
8. Wang D, Kong L, Wang J, He X, Li X, Xiao Y. Polymyxin E sulfate-loaded liposome for intravenous use: preparation, lyophilization, and toxicity assessment in vivo. PDA J Pharm Sci Technol. 2009; 63: 159-67.
9. Santos Magalhaes NS, Fessi H, Puisieux F, Benita S, Seiller M. An in vitro release kinetic examination and comparative evaluation between submicron emulsion and polylactic acid nanocapsules of clofibride. J Microencapsul. 1995; 12: 195-205.
10. Ozer AY, Talsma H. Preparation and stability of liposomes containing 5-fluorouracil. Int J Pharm. 1989; 55: 185-91.
11. Cui J, Li C, Deng Y, Wang Y, Wang W. Freeze-drying of liposomes using tertiary butyl alcohol/water cosolvent systems. Int J Pharm. 2006; 312: 131-6.
12. Boyd BJ. Characterisation of drug release from cubosomes using the pressure ultrafiltration method. Int J Pharm. 2003; 260: 239-47.
13. Ammoury N, Fessi H, Devissaguet JP, Puisieux F, Benita S. In vitro release kinetic pattern of indomethacin from poly(d, l-lactide) nanocapsules. J Pharm Sci. 1990; 79: 763-7.
14. Henriksen I, Sverre AS, Gro S, Karlsen J. In vitro evaluation of drug release kinetics from liposomes by fractional dialysis. Int J Pharm. 2005; 119: 231-8.
15. Johnston MJ, Edwards K, Karlsson G, Cullis PR. Influence of drug-to-lipid ratio on drug release properties and liposome integrity in liposomal doxorubicin formulations. J Liposome Res. 2008; 18: 145-57.
16. Chidambaram N, Burgess DJ. A novel in vitro release method for submicron sized dispersed systems. AAPS PharmSci. 1999; 1: E11.
17. Avgoustakis K, Beletsi A, Panagi Z, Klepetsanis P, Karydas AG, Ithakissios DS. PLGA-mPEG nanoparticles of cisplatin: in vitro nanoparticle degradation, in vitro drug release and in vivo drug residence in blood properties. J Control Release. 2002; 79: 123-35.
18. Saarinen-Savolainen P, Jarvinen T, Taipale H, Urtti A. Methods for evaluating drug release from liposomes in sink conditions. Int J Pharm. 1997; 159: 27-33.
19. Sezer AD, Akbuga J, Bas AL. In vitro evaluation of enrofloxacin-loaded MLV liposomes. Drug Deliv. 2007; 14: 47-53.
20. Muthu MS, Singh S. Poly (d, l-lactide) nanosuspensions of risperidone for parenteral delivery: formulation and in-vitro evaluation. Curr Drug Deliv. 2009; 6: 62-8.
21. D'Souza SS, DeLuca PP. Methods to assess in vitro drug release from injectable polymeric particulate systems. Pharm Res. 2006; 23: 460-74.
22. Rosenblatt KM, Douroumis D, Bunjes H. Drug release from differently structured monoolein/poloxamer nanodispersions studied with differential pulse polarography and ultrafiltration at low pressure. J Pharm Sci. 2007; 96: 1564-75.
23. Nation RL, Li J. Colistin in the 21st century. Curr Opin Infect Dis. 2009; 22: 535-43.
24. Falagas ME, Kasiakou SK. Colistin: the revival of polymyxins for the management of multidrug-resistant Gram-negative bacterial infections. Clin Infect Dis. 2005; 40: 1333-41.
25. Wallace SJ, Li J, Nation RL, Prankerd RJ, Velkov T, Boyd BJ. Self-assembly behavior of colistin and its prodrug colistin methanesulfonate: implications for solution stability and solubilization. J Phys Chem B. 2010; 114: 4836-40.
26. Bangham AD. Membrane models with phospholipids. Prog Biophys Mol Biol. 1968; 18: 29-95.
27. Gales AC, Reis AO, Jones RN. Contemporary assessment of antimicrobial susceptibility testing methods for polymyxin B and colistin: review of available interpretative criteria and quality control guidelines. J Clin Microbiol. 2001; 39: 183-90.
28. Lide DR. Handbook of chemistry and physics. 76th ed. New York: CRC Press; 1995.
29. Wallace SJ, Li J, Rayner CR, Coulthard K, Nation RL. Stability of colistin methanesulfonate in pharmaceutical products and solutions for administration to patients. Antimicrob Agents Chemother. 2008; 52: 3047-51.
30. Lasch J. Isothermic microcalorimetry. In: Torchillin VP, Weissig V, editors. Liposomes: a practical approach. 2nd ed. Oxford, UK: Oxford University Press; 2003.
31. New RRC. Liposomes: a practical approach. Oxford: IRL Press; 1990.
32. Heeremans JL, Gerritsen HR, Meusen SP, Mijnheer FW, Gangaram Panday RS, Prevost R, et al. The preparation of tissue-type plasminogen activator (t-PA) containing liposomes: entrapment efficiency and ultracentrifugation damage. J Drug Target. 1995; 3: 301-10.
33. Clausell A, Garcia-Subirats M, Pujol M, Busquets MA, Rabanal F, Cajal Y. Gram-negative outer and inner membrane models: insertion of cyclic cationic lipopeptides. J Phys Chem B. 2007; 111: 551-63.
34. Benita S, Levy MY. Submicron emulsions as colloidal drug carriers for intravenous administration: comprehensive physicochemical characterization. J Pharm Sci. 1993; 82: 1069-79.
35. Levy MY, Benita S. Drug release from submicronised o/w emulsion: a new in vitro kinetic evaluation model. Int J Pharm. 1990; 66: 29-37.